Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

BioAtla, Inc.

OTC: BCAB · Life Sciences · 3 alerts · CIK 1826892

Share price
$1.99Close, Nov 16
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All BioAtla, Inc. filings on SEC EDGAR ↗

9:03 AM ET 10-Q
Financial Results

BioAtla Q3 2026 Results: Net Loss of $7.9M, Loss Narrows

BioAtla, Inc. reported a significant reduction in net loss to $13.8 million for the first nine months of 2026, compared to $49.8 million in the prior year, primarily driven by $6.8 million in collaboration revenue and a sharp decrease in R&D spending. However, the company's liquidity position is critical, with cash and cash equivalents dropping to $0.6 million as of September 30, 2026, and a total stockholders' deficit of $43.6 million.

Key figure
Net loss $7.9M
6:03 AM ET 8-K
Capital Raise

BioAtla Capital Raise

BioAtla, Inc. entered into a Standby Equity Purchase Agreement (SEPA) with Yorkville, establishing a facility to sell up to $40.0 million of common stock at the company's option. Shares will be sold at 97% of the lowest daily VWAP over a three-day pricing period following an advance notice. As consideration, the company agreed to pay a $500,000 commitment fee, partially settled through the issuance of warrants for 182,110 shares.

Counterparty
YA II PN, Ltd.
Term
36 months

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.